BIT
CRL icon

BlackRock Institutional Trust’s Charles River Laboratories CRL Stock Holding History

BlackRock Institutional Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$113M Buy
1,479,527
+20,795
+1% +$1.58M 0.02% 848
2016
Q3 		$122M Sell
1,458,732
-101,626
-7% -$8.52M 0.02% 773
2016
Q2 		$129M Buy
1,560,358
+157,909
+11% +$13M 0.02% 729
2016
Q1 		$107M Sell
1,402,449
-28,960
-2% -$2.14M 0.02% 801
2015
Q4 		$115M Buy
1,431,409
+96,373
+7% +$6.95M 0.02% 760
2015
Q3 		$84.8M Sell
1,335,036
-19,688
-1% -$1.41M 0.01% 928
2015
Q2 		$95.3M Sell
1,354,724
-24,116
-2% -$1.78M 0.02% 917
2015
Q1 		$109M Buy
1,378,840
+34,337
+3% +$2.53M 0.02% 872
2014
Q4 		$85.6M Buy
1,344,503
+17,525
+1% +$1.1M 0.01% 965
2014
Q3 		$79.3M Sell
1,326,978
-55,856
-4% -$3.2M 0.01% 982
2014
Q2 		$74M Sell
1,382,834
-69,401
-5% -$3.81M 0.01% 1056
2014
Q1 		$87.6M Buy
1,452,235
+101,144
+7% +$5.9M 0.02% 947
2013
Q4 		$71.7M Buy
1,351,091
+48,866
+4% +$2.45M 0.01% 1045
2013
Q3 		$60.2M Sell
1,302,225
-27,348
-2% -$1.25M 0.01% 1088
2013
Q2 		$54.6M Buy
+1,329,573
New +$57M 0.01% 1096

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock Institutional Trust's CRL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Charles River Laboratories (CRL) stake by 1.4% in Q4 2016, buying an estimated $1.58M and bringing the position to 1,479,527 shares worth $113M. The position accounts for 0.02% of the portfolio, ranked #848.

BlackRock Institutional Trust first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $129M in Q2 2016. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Institutional Trust held 1,479,527 shares of Charles River Laboratories worth $113M as of Q4 2016.
  • BlackRock Institutional Trust bought 20,795 Charles River Laboratories shares in Q4 2016, an estimated $1.58M.
  • Charles River Laboratories made up 0.02% of BlackRock Institutional Trust's portfolio in Q4 2016, its #848 holding.
  • BlackRock Institutional Trust first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Charles River Laboratories position peaked at $129M in Q2 2016.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.